BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 26, 2026
Home » SARS-CoV-2

Articles Tagged with ''SARS-CoV-2''

Regulatory actions for Jan. 21, 2021

Jan. 21, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Canon Medical Systems, Covaxx, Lumiradx, Retia Medical, Zimmer Biomet.
Read More

Other news to note for Jan. 21, 2021

Jan. 21, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aiforia, Atc Alert, Berkshire Biomedical, Biotheranostics, Brain Scientific, Bruker, Cairnsurgical, Canadian Hospital Specialties, Carenity, Cerba Research, Echosens, Electrocore, Erba Mannheim, Fortress Medical Systems, Helix, Imbiotechnologies, Inivata, Natera, Numares, Orasure, Pathan, Polarityte, Premier Medical Laboratory Services, Qiagen, Thomas Scientific, Viveve, Xclinical.
Read More

Broader vaccine Gritstone quarry; will COVID-19 Vir in new direction?

Jan. 21, 2021
By Randy Osborne
With worrisome COVID-19 variants cropping up, developers including the likes of Gritstone Oncology Inc. and Vir Biotechnology Inc. continue their efforts to invent new vaccines that may get around the drawbacks of existing shots if they turn up.
Read More

Regulatory actions for Jan. 20, 2021

Jan. 20, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Lightpoint Medical, Omniguide Holdings, Renegade.bio.
Read More
Coronavirus variants

New concerns raised about effectiveness of vaccines for COVID-19 variants

Jan. 20, 2021
By Nuala Moran
LONDON – There’s mixed news about emerging variants of SARS-CoV-2, with Pfizer Inc. and Biontech SE reporting their vaccine Comirnaty maintains its protective effect against B 1.1.7, first detected in the U.K., while researchers in South Africa say virus variant 501Y.V2 is able to escape neutralization by both monoclonal antibodies and convalescent plasma from previously infected individuals.
Read More
Coronavirus spike protein

Trying to stay ahead of SARS-CoV-2 as variants emerge

Jan. 19, 2021
By Nuala Moran
LONDON – A new national consortium of virologists has been set up to systematically assess how mutations in SARS-CoV-2 affect key outcomes such as effectiveness of vaccines and therapies, transmissibility of the virus and the severity of COVID-19 infections.
Read More

Other news to note for Jan. 19, 2021

Jan. 19, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alithya Group, Applied DNA Sciences, Applied Stemcell, Artms, Bardy Diagnostics, Cardialen, Cogme, Cue Health, Diaceutics, Electrocore, Guardant Health, Gns Healthcare, Hamilton Storage, Helius Medical Technologies, Hillrom, Integrated DNA Technologies, Intersect ENT, Isotopia Molecular Imaging, Mayo Clinic Laboratories, Menon Biosensors, Mindup, Neovasc, Physiq, Qiagen, Rhinostics, Sensorion, Serotiny, Twist Bioscience, Vivos.
Read More
Woman gets COVID-19 vaccine in Brazil
Vaccination started in minutes

Brazil approves Coronavac and Covishield COVID-19 vaccines, turns Sputnik V back

Jan. 19, 2021
By Sergio Held
CAJICA, Colombia – Brazil’s health care surveillance agency, Anvisa, granted the first two emergency approvals for COVID-19 vaccines on Sunday, Jan. 17, giving the green light to Sinovac Biotech Ltd.’s Coronavac and to Covishield, developed by Astrazeneca plc and the University of Oxford.
Read More

Regulatory actions for Jan. 15, 2021

Jan. 15, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Motus GI, Sml Genetree.
Read More

Other news to note for Jan. 15, 2021

Jan. 15, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accolade, Beyond Medical Technologies, Biomagnetic Solutions, Carepics, City of Hope, Clearpoint Neuro, Eurofins, Fuse Medical, Galaxy Pharma, Gamma Biosciences, Innovation Specialists, Invo Bioscience, Kayan Health, Mammoth Biosciences, Mriglobal, Novasep, Novisci, Orthopediatrics, Target Rwe, Thermo Fisher Scientific.
Read More
Previous 1 2 … 70 71 72 73 74 75 76 77 78 … 136 137 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 24, 2026.
  • Cell nucleus architecture

    4D Nucleome opens new wave of gene regulation research, discovery

    BioWorld
    After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
  • Other news to note for July 22, 2026

    BioWorld
    Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
  • Drug capsule spilling onto brain

    Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s

    BioWorld Science
    Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
  • Lung cancer illustration

    GSK’s newly acquired Jideytro wins FDA nod in NSCLC

    BioWorld
    About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing